BBIO: Notice to Sell 140,000 Common Shares

BBIO proposes the sale of 140,000 shares of Common stock as indicated on the notice.

Rhea-AI Filing Summary

BBIO proposes the sale of 140,000 shares of Common stock as indicated on the notice.

The filing lists multiple prior 10b5-1 sales by related parties, including recent transactions by Kumar Haldea Revocable Trust and Neil Kumar on 03/12/2026 and 02/19/2026. Examples shown include 20,000 shares sold on 03/12/2026 and 28,053 shares sold on 02/19/2026.

Insights

Securities Attorney

Notice documents proposed resale of 140,000 shares and lists prior 10b5-1 sales.

The notice identifies a 140,000 share amount of Common stock associated with the filing and documents prior executed 10b5-1 sales by related trusts and an individual on explicit dates. The filing text ties specific sale dates and share counts to named trust and individual sellers.

Legal implications primarily concern compliance with Rule 144 transfer restrictions and the documented automatic-plan sales; timing and proceeds treatment are as stated in the form. Subsequent filings would show settlement details if and when sales occur.

Equity Capital Markets Analyst

Routine resale notification with documented rule‑based sales; transaction scale is modest relative to typical floats.

The filing lists multiple prior sales executed under 10b5-1 plans with per-trade proceeds shown (for example 1,374,660.00 on 03/12/2026). The primary action is a registration/notice of up to 140,000 shares.

Cash-flow treatment and any issuer proceeds are not itemized here; market impact depends on actual execution and remaining holdings disclosed in other filings. Further position detail would appear in Form 4/5 or later disclosures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the BBIO Form 144 disclose?

The Form 144 discloses a proposed sale of 140,000 shares of Common stock and lists prior 10b5-1 sales by related parties on specific dates, including transactions on 03/12/2026 and 02/19/2026.

Who executed recent 10b5-1 sales listed in the filing for BBIO?

Recent listed sales were executed by entities including Kumar Haldea Revocable Trust, Kumar Haldea Family Irrevocable Trust, and Neil Kumar, with trade dates such as 03/12/2026 and 02/19/2026.

How large were example trades shown in the BBIO filing?

Example trades include sales of 20,000 shares on 03/12/2026 with proceeds around 1,374,660.00 and 28,053 shares on 02/19/2026 with proceeds around 2,002,717.70, as listed in the form.

Does the Form 144 state who receives proceeds for these BBIO sales?

The filing lists the selling parties by name (trusts and an individual) and per-trade proceeds; it does not state issuer receipt of proceeds or use of proceeds in this excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/13/2026 - 04:22 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001742485
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BridgeBio Pharma, Inc.
SEC File Number	001-38959
Address of Issuer	3160 PORTER DRIVE SUITE 250 Palo Alto CALIFORNIA 94304
Phone	6503919740
Name of Person for Whose Account the Securities are To Be Sold	KUMAR HALDEA FAMILY IRREVOCABLE TRUST
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	140000	9517200.00	193862871	03/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/26/2016	Conversion Management Incentive Units	Issuer			140000	03/26/2016	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	03/12/2026	20000	1374660.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	03/12/2026	20000	1374604.00
10b5-1 Sales for NEIL KUMAR 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/19/2026	28053	2002717.70
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/11/2026	20000	1435544.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/11/2026	20000	1435542.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/10/2026	20000	1438758.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/10/2026	20000	1438822.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/09/2026	20000	1542114.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/09/2026	20000	1542198.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/08/2026	20000	1479432.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/08/2026	20000	1479422.00
10b5-1 Sales for NEIL KUMAR 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/15/2025	30011	2239901.00

144: Remarks and Signature

Remarks
Date of Notice	03/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Kumar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)